In Vitro Bioactivity, Cytocompatibility, and Antibiotic Release Profile of Gentamicin Sulfate-Loaded Borate Bioactive Glass/Chitosan Composites
Borate bioactive glass-based composites have been attracting interest recently as an osteoconductive carrier material for local antibiotic delivery. In the present study, composites composed of borate bioactive glass particles bonded with a chitosan matrix were prepared and evaluated in vitro as a carrier for gentamicin sulfate. The bioactivity, degradation, drug release profile, and compressive strength of the composite carrier system were studied as a function of immersion time in phosphate-buffered saline at 37 °C. The cytocompatibility of the gentamicin sulfate-loaded composite carrier was evaluated using assays of cell proliferation and alkaline phosphatase activity of osteogenic MC3T3-E1 cells. Sustained release of gentamicin sulfate occurred over ~28 days in PBS, while the bioactive glass converted continuously to hydroxyapatite. The compressive strength of the composite loaded with gentamicin sulfate decreased from the as-fabricated value of 24 ± 3 MPa to ~8 MPa after immersion for 14 days in PBS. Extracts of the soluble ionic products of the borate glass/chitosan composites enhanced the proliferation and alkaline phosphatase activity of MC3T3-E1 cells. These results indicate that the gentamicin sulfate-loaded composite composed of chitosan-bonded borate bioactive glass particles could be useful clinically as an osteoconductive carrier material for treating bone infection.
X. Cui et al., "In Vitro Bioactivity, Cytocompatibility, and Antibiotic Release Profile of Gentamicin Sulfate-Loaded Borate Bioactive Glass/Chitosan Composites," Journal of Materials Science: Materials in Medicine, vol. 24, no. 10, pp. 2391-2403, Springer New York, Oct 2013.
The definitive version is available at https://doi.org/10.1007/s10856-013-4996-0
Materials Science and Engineering
International Standard Serial Number (ISSN)
Article - Journal
© 2013 Springer New York, All rights reserved.